Market research future has a half cooked research report on Global Ureteral Obstruction
Market. The Global Ureteral Obstruction Market is growing at a rate of 8.5 % and is
expected show a similar trend during the forecast period.
Ureteral obstruction or urinary tract obstruction is a condition of blockage of urine through
the urinary tract, which may be complete or partial. In Ureteral obstruction the urine may
refluxes backward into your kidneys. Ureteral obstruction is curable, but if not treated, can
lead to loss of kidney function, sepsis and eventually death. Other severe consequences are
kidney stones, and infection of the urinary tract. Mild symptoms generally in partial
blockage are pain in a side, abnormal urine flow and urinating at night, acute stinging pain
etc. Ureteral obstruction is caused by injuries such as a pelvic fracture, ureter, kidneys,
bladder or colon cancers, kidney stones in ureter etc.
Considering all these factors, the Ureteral Obstruction Market is expected to grow at a CAGR
of ~ 8.5 % during 2017-2023.
The Ureteral Obstruction Market is highly fragmented due to large number of players
especially in the devices segment which has put pressure on the profit margin, rise of low
quality and low cost products especially catheters which reduces the market of high quality
products. Also the market for ureteral obstruction is highly dependent on product
development strategy such as miniaturization of ureter stents, development of coated ureter
stents. The drug segment is growing at a slow pace due to saturation of the market.
Global Ureteral obstruction market Players:
C. R. Bard, Inc., Boston Scientific Corporation, Cook Medical Inc., Medline Industries, Inc.,
Coloplast A/S, DISA Vascular, Terumo Europe NV, Medtronic, Novartis AG, Johnson and
Johnson and others.
Sample Copy @ https://www.marketresearchfuture.com/sample_request/4041 .
Segmentation:
The Global Ureteral Obstruction Market is segmented on the basis of type, diagnosis,
treatment, equipment and end users. Based on type, the market has been segmented as
acute and chronic. Based on the diagnosis, the market has been segmented as ultrasound,
bladder catheterization, computed tomography (CT), magnetic resonance imaging (MRI),
voiding cystourethrography (VCUG), pyelography, endoscopy, blood and urine tests and
others. Based on the treatment, the market has been segmented as surgery (ureteral stent,
nephrostomy, open laparoscopy, catheterization, robot-assisted laparoscopy, others) and
drugs (antibiotics, pain killers, others). Based on the equipment, the market has been
segmented as devices (catheters, stents, others) and consumables (diagnostic reagents,
urinary sample collectors, others) and others. Based on the end users, the market has been
segmented as hospitals and clinics, research, others.
Regional analysis:
US accounts for the maximum market share due to greater use of medications and greater
expenditure on healthcare. The faster market uptake of new technology and devices in the
US is also an important driver of the market for global ureteral obstruction. The presence of
large device companies in the developed regions is also a major driver of the market.
Europe is the second largest market due to large disposable income and rising awareness
regarding the health hazards of this condition. Asia Pacific region is expected to have the
most future potential and it is estimated to be led by China and India. The Middle East &
Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of
Africa are expected to witness a moderate growth due to poor economic and political
conditions and poor healthcare penetration.
Table of Contents
1. Introduction
1.1 Definition